Liminatus Pharma, Inc. (LIMN) - Latest Market Data

Price & Market Data

Price: $0.20

Daily Change: -$0.005 / 2.50%

Daily Range: $0.19 - $0.21

Market Cap: $8,594,066

Daily Volume: 696,452

Performance Metrics

1 Week: -7.93%

1 Month: 6.39%

3 Months: -84.80%

6 Months: -83.56%

1 Year: -97.31%

YTD: -68.61%

About Liminatus Pharma, Inc. (LIMN)

Essential market overview for Liminatus Pharma, Inc. (LIMN). Current price: 0.20, daily change: -$0.005 / 2.50%. Market cap: 8,594,066. All key performance metrics for a full analysis.

Company Details

Employees: 1

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

Liminatus Pharma, Inc., a pre-clinical stage biopharmaceutical company, engages in the development of cancer therapies in the United States. It develops IBA101, a humanized anti CD47 monoclonal antibody, which is in Phase I clinical trial for the treatment of advanced solid cancers, including non-small cell lung cancer. The company was founded in 2018 and is based in Cerritos, California.

Selected stocks

Bain Capital GSS Investment Corp. (BCSS-UN)

Merchants Bancorp - Depositary Shares, Each Representing a 1/40th Interest in a Share of 7.625% Fixed Rate Series E Non-Cumulative Perpetual Preferred Stock, wi (MBINL)

Ondas Inc (ONDS)

First Merchants Corporation - Depository Shares, each representing a 1/100th interest in a share of 7.50% Non-Cumulative Perpetual Preferred Stock, A (FRMEP)